We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1004 | 5.70454545455 | 1.76 | 1.97 | 1.7301 | 12802 | 1.8328209 | CS |
4 | -0.1096 | -5.56345177665 | 1.97 | 2.1 | 1.65 | 17894 | 1.85804784 | CS |
12 | 0.4004 | 27.4246575342 | 1.46 | 2.3399 | 1.31 | 108214 | 1.98879857 | CS |
26 | 0.5404 | 40.9393939394 | 1.32 | 2.3399 | 1.18 | 80299 | 1.80557024 | CS |
52 | -3.3096 | -64.0154738878 | 5.17 | 26.4 | 1.08 | 1235717 | 10.31922227 | CS |
156 | -795.8596 | -99.7667853382 | 797.72 | 840.84 | 1.08 | 2914112 | 148.31076696 | CS |
260 | -1913.8996 | -99.9028897148 | 1915.76 | 4989.6 | 1.08 | 2598106 | 329.7103461 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions